Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
LONDON, Jan. 18, 2022 /PRNewswire/ -- Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it...
Source: businessinsider.com